ERLOCIP (Erlotinib or Tarceva) is monotherapy treatment for advanced or metastatic non-small cell lung cancer 150 mg once daily. Erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. For more : http://www.healthcare247.co/category/cancer-therapy
Geupload: op December 25, 2014 door healthcare247
Waardering: (0 Stemmers)
Report
Other Formats
Download
Log in om te stemmen!
Views: 264
Reacties
Reactie toevoegen
Log in om een reactie te plaatsen!